QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Spherix Inc. (SPEX) Reports Progress On Phase 3 Trial for Diabetes Drug 1 comment
    May 21, 2010 5:34 PM | about stocks: SPEX

    Spherix Inc. reported progress on a Phase 3 clinical trial for its new drug to treat Type 2 diabetes and expects results in the third quarter of 2010.

    Spherix is developing D-tagatose, which is used to reduce blood sugar levels in patients suffering from Type 2 diabetes. D-tagatose works by decreasing glycogen utilization in the body, which leads to better control of blood sugar.

    Spherix has two clinical trials underway for D-tagatose with the Food and Drug Administration (FDA) under the Investigational New Drug Application (NDA) format with the agency. The company has a Phase 2 trial to evaluate D-tagatose for use at lower doses, and a Phase 3 trial to evaluate the safety and efficacy of the drug.

    D-tagatose is a naturally occurring sugar that is approved by the FDA as a Generally Recognized As Safe (OTCPK:GRAS) food ingredient. Spherix holds the patents on the use of D-tagatose to treat Type 2 diabetes.

    Spherix has signed a manufacturing supply agreement with Inalco S.p.A. to produce large scale quantities of D-tagatose if the drug is approved for use by the FDA.

    For more information on the company, go to spherix.com

    Please see disclaimer on QualityStocks website: disclaimer.qualitystocks.net


    Disclosure: no positions
    Stocks: SPEX
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (1)
Track new comments
  • nasdaqczar
    , contributor
    Comments (71) | Send Message
    spex goto new 52 week highs takeover coming a sale of the company trial ends july 13 eom
    8 Jun 2010, 01:35 AM Reply Like
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.